Paper · 2025 · Open access

Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives

Vaishnavi Patil, Sonam Babaso Kamble, Dr. Dhanraj Raghunath Jadge

Zenodo (CERN European Organization for Nuclear Research) · Published 8 November 2025 · DOI 10.5281/zenodo.17556719

Read the free full textCite this paper

In brief

“Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives” is a 2025 paper by Vaishnavi Patil, Sonam Babaso Kamble, Dr. Dhanraj Raghunath Jadge, published in Zenodo (CERN European Organization for Nuclear Research). OpenAlex counts 2 citations as of 15 November 2026, which puts it in the top 5% of works published in 2025 by citations. It is open access under a CC BY licence: the full text is free to read at Zenodo (CERN European Organization for Nuclear Research).

Citations
2
Most cited in
2026 (2)
Field-weighted impact
0.57
Authors
1

Abstract

Artificial intelligence (AI) has emerged as a transformative technology across multiple domains of healthcare and pharmaceutical sciences. From early applications in data management to advanced uses in drug discovery, clinical trials, manufacturing, and pharmacovigilance, AI has progressively reshaped the pharmaceutical landscape. The integration of machine learning, deep learning, and natural language processing has enabled researchers to accelerate drug development pipelines, improve decision-making, reduce costs, and enhance patient outcomes. This review explores the current applications of AI in the pharmaceutical industry, focusing on drug discovery and design, preclinical research, clinical trials, pharmaceutical manufacturing, and pharmacovigilance. Furthermore, the review provides a forward-looking perspective on the future role of AI in precision medicine, personalized drug development, regulatory sciences, and sustainable manufacturing practices. Despite remarkable progress, challenges related to data privacy, interpretability, regulatory acceptance, and ethical considerations remain. Addressing these challenges will be crucial to fully harness the potential of AI in pharmaceutical sciences. Remarkable break throughs in Machine learning and AI technology provide a revolutionary potential in drug discovery, the creation, testing, and formulation of medicinal dosage forms. Using artificial intelligence (AI) algorithms which judge the situation. Using comprehensive biological information, such as genomics and proteomics, researchers can pinpoint disease-associated targets and forecast how they will interact with potential drug candidates. This skill allows for the prioritization of and improving lead compounds, which lessens the demand for rigorous and expensive animal testing.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Jadge, V. P. S. B. K. D. D. R. (2025). Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.17556719

MLA 9

Jadge, Vaishnavi Patil, Sonam Babaso Kamble, Dr. Dhanraj Raghunath. “Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives.” Zenodo (CERN European Organization for Nuclear Research), 2025. https://doi.org/10.5281/zenodo.17556719.

Chicago

Jadge, Vaishnavi Patil, Sonam Babaso Kamble, Dr. Dhanraj Raghunath. 2025. “Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives.” Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.17556719.

Harvard

Jadge, V. P. S. B. K. D. D. R. (2025) ‘Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives’, Zenodo (CERN European Organization for Nuclear Research). doi:10.5281/zenodo.17556719.

IEEE

V. P. S. B. K. D. D. R. Jadge, “Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives,” Zenodo (CERN European Organization for Nuclear Research), 2025, doi: 10.5281/zenodo.17556719.

BibTeX

@article{jadge2025artificial,
  title     = {{Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives}},
  author    = {Jadge, Vaishnavi Patil, Sonam Babaso Kamble, Dr. Dhanraj Raghunath},
  journal   = {Zenodo (CERN European Organization for Nuclear Research)},
  year      = {2025},
  doi       = {10.5281/zenodo.17556719},
  url       = {https://doi.org/10.5281/zenodo.17556719}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • artificial intelligence in pharmaceuticals
  • drug discovery
  • drug design
  • clinical trials
  • pharmaceutical manufacturing
  • pharmacovigilance
  • precision medicine
  • regulatory science

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Jadge, V. P. S. B. K. D. D. R. (2025). Artificial Intelligence in Pharmaceutics: Applications and Future Perspectives. Zenodo (CERN European Organization for Nuclear Research). https://doi.org/10.5281/zenodo.17556719

How many times has this paper been cited?

2 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access: read the free full text at Zenodo (CERN European Organization for Nuclear Research).

Who wrote this paper?

Vaishnavi Patil, Sonam Babaso Kamble, Dr. Dhanraj Raghunath Jadge.

What is the DOI of this paper?

10.5281/zenodo.17556719. The permanent link is https://doi.org/10.5281/zenodo.17556719.

Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.